Browse Category: Cancer

Eric Lefkofsky’s Involvement on Cancer Treatment

There is a lot of fulfillment that comes along with giving back to the community. Eric Lefkofsky has experienced this feeling. Together with his wife Liz, he started a charitable family foundation in the year 2006. Through this foundation, Lefkofsky can address numerous issues that affect individuals such as human rights, medical research as well as arts. The family foundation aims at funding programs that can impact on the lives of many people and improve the quality of life that the individuals lead. Through this family foundation, Eric has reached out to the undeserved people in Chicago. He, therefore, supports programs help to advance the cause of education such as After School Matter and Teach for America and more information click here.

In the year 1991, Eric Lefkofsky graduated from the University of Michigan. Two years later, he was conferred with the Juris Doctor from the University of Michigan School of law. He has over the years founded various companies that are based on technology such as Groupon, Lightbank, and Echo Global Logistics among many others. As much as these companies focus on different businesses, one thing is common about them. They use the new technology.

In the year 2016, Eric co-founded Tempus and was named its chief executive officer. The organization is a healthcare startup that primarily focuses on creating an operating system that can assist in collecting and analyzing data, which is associated with genetics and cancer treatment. Tempus compiles the genetic profiles of the cancer patients and puts them into one database. This way, the doctors have fast access to the information on the effective treatment of a particular patient. The organization hopes that both physicians and patients can fight cancer by using data of other patients across the country. Eric was motivated to co-find Tempus after a close relative was diagnosed with cancer. He has continued to give donations to cancer patients across Chicago and the country at large and learn more about Eric.

Besides being an entrepreneur, Eric is an author. He has written a book known as Accelerated Disruption, which explains why businesses that integrate new technologies in their endeavors are more likely to succeed and Eric’s lacrosse camp.

More visit: https://www.tempus.com/about-us/

Oncotarget Publication Increasing the Impact of Science

Oncotarget is a traditional journal that is published every week. The journal covers the research made on all the oncology aspects. The journal has free access and is multidisciplinary. The publication is made online, and it can be printed if one made a special demand. Oncotarget aims at making the results of science widely available to the people. The journal also wants to use the insightful reviews they get to increase the impact the research has. It has tried to get rid of the borders the specialties have and to ensure that those special discoveries that are made are shared as fast as possible. The company has links to various biochemical science fields, and they use this to come up with the application of the clinical science to fight the illnesses.

Oncotarget was created in the year 2010. Impact Journals publishes the paper. The publication has two editors-in-chief. They are; Andrei Gudkov, Mikhail Blagosklonny. Andrei is from the Cancer Institute of Roswell Park. Since the issuance begun, it has published more than 350 papers that have topics related to oxygen. William Kaelin, Jr. and Gregg Semenza are also members of the team. They were awarded the Lasker Award because they discovered the pathway of sensing oxygen. Oncotarget also makes publication from the cancer research papers. The paper will also tend to make some articles on immunology, age-related diseases, Pharmacology, Mol Biology and cell, and pathology. This is because of the integrity of the human organism and the fact that tumor development is a complex issue.

Oncotarget helps researchers to contribute to the progress in the field of science. It does this by having leadership that is of prominent scientists. The paper aims at seeing individuals live without diseases. The success of the publication is what encouraged the paper to deal with other sections apart from oncology. The paper has a board that ensures the issues that are published are only the best ones. They play a major role in the success of journal. They are devoted and have had experience of several years.

Oncotarget goes ahead to allow authors from outside to submit any publications that they have on the related topics. The people who have an interest in writing issues on the same subject now have opportunities. However, they also work to ensure that the articles submitted are of high quality. To them, quality is everything. For this reason, all the writers who wish to submit what they write have to pass all their ethical tests to ensure it is of top quality.

To know more visit @: www.linkedin.com/in/mikhail-blagosklonny-91abb531/